Abstract-The calcium-channel blocking action of franidipine (CV-4093.2HCI) was investigated in vitro and in vivo. CV-4093.2HCI inhibited the 60 mM K+ induced contraction of rabbit aorta and those of coronary, renal, mesenteric and femoral arteries of dog less potently than nifedipine and nicardipine. In dog portal and femoral veins, CV-4093.2HCI inhibited K+-induced contraction as potently as nifedipine and nicardipine did. The inhibitory effect of this drug was fully developed by pretreatment for 60 min, and it lasted long after washout. The drug inhibited both K+-induced 45Ca-influx and K+-induced contraction at a similar concentration range in rabbit aorta and dog portal vein, but had no effect on 45Ca efflux from either vessel. On the other hand, in the isolated, perfused kidneys and mesenteric vascular beds of SHR, CV-4093.2HCI inhibited K+-induced vasocon striction more effectively than did nifedipine. Moreover, in pithed rats (1.v.) and ganglion-blocked conscious SHR (p.o.), CV-4093.2HCI inhibited more potently a2-adrenergic pressor responses than did nicardipine. These pharmacological properties of CV-4093.2HCI, especially those seen in the isolated, perfused kidney and mesenteric vascular beds, may be responsible for its potent and long-lasting action as an antihypertensive agent.
It has been established that so called "Ca channel blockers" are very useful for treating such diseases as angina pectoris and hyper tension (1) (2) (3) (4) (5) , since "Ca-channel blockers" prevent and resolve coronary vasospasm and potently relax arteries and veins by inhibiting the influx of Call into the smooth muscle cells, which is responsible for the contraction of the blood vessels.
Recently, Meguro et al. (6) reported the synthesis of a new 1,4-dihydropyridine derivative, methyl 2-(4-diphenylmethyl-1 piperazinyl)ethyl (+)-1,4-dihydro-2,6-dime thyl-4-(m-nitrophenyl)-3,5-pyridine-dicar boxylate dihydrochloride (CV-4093.2HC1), with a potent and long-lasting antihyper tensive property in SHR. Okabe et al. (7) have reported the inhibitory actions of CV 4093.2HC1 on the calcium current in single smooth muscle cells of rabbit main pulmonary artery, indicating that CV-4093.2HCI has highly selective and long-lasting inhibitory actions on the Ca++-induced current.
In the present report, the "Ca-channel blocking action" of CV-4093.2HC1 was compared in isolated vessels, pithed rats, and ganglion blocked conscious SHR with those of nifedipine and nicardipine.
Materials and Methods 1. Effects on isolated vascular smooth muscles: The thoracic aorta (outer diameter: 4-5 mm) isolated from male albino rabbits and arteries (renal, femoral, coronary and mesenteric, outer diameter: 2-3, 1-2, 1-2 and 2-3 mm, respectively) and veins (femoral and portal, outer diameter: 2-3 mm) isolated from mongrel dogs of both sexes were used. After the vessels were isolated, the rabbit thoracic aorta and the dog renal, femoral, coronary and mesenteric arteries were cut into spiral strips (2 mm in width, 3 cm in length); and dog portal vein and femoral vein were cut longitudinally (2 mm in width, 1.5 cm in length). The preparations were suspended with loads of 1 or 2 g in 20 ml organ baths at 37'C containing Krebs Henseleit solution oxygenated continuously with 5% CO2 in oxygen. At the beginning of the experiments, the strips were stretched to an initial tension and then allowed to equilibrate for 2 to 3 hr in the bathing medium, which was changed every 15 min. After the contractile response of the strips to 60 mM KCI was stabilized, the experiments were started. The tension of the strips was recorded isometrically with electromechanical trans ducers (TB-611T, Nihon Kohden, Japan) and a polygraph (R-1500, Nihon Kohden).
The kidneys isolated from SHR (15 weeks old, male) were perfused with Krebs Henseleit solution saturated with 5% CO2 in oxygen according to the method described previously (8) . The basal perfusion flow rate was 3-3.5 ml/g kidney/min, and the per fusion pressure was set at 60-70 mmHg. Mesenteric arterial vascular beds of SHR were isolated and perfused with the Krebs Henseleit solution according to McGregor (9) . The perfusion flow rate was 10 mi/min. Each drug was infused into the renal or mesenteric artery at a rate of 0.1 ml/min for 30 min. KCI was injected in a volume of 0.1 ml.
2 45Ca-influx experiments: The lanthanum method (10) was used. About 30 mg of rabbit aorta rings and dog portal vein, which was cut longitudinally, were used. After the preparation was fully oxygenated, the vessels were incubated at 37°C for 1 hr in buffer A, which was adjusted to pH 7.4 with NaOH. Buffer A consisted of 140 mM NaCI, 2.7 mM KCI, 1.25 mM CaCl2, 1 MM MgCl2, 10 MM glucose and 5 mM Tris-HCI (pH 7.4). The vessels were then incubated in buffer A containing CV-4093,2110 and nicardipine for 30 to 60 min and then further incubated in 1 ml of buffer A containing KCI (2.7, 60 and 123 mM), 1.25 MM 45CaC12 (1.55 fCi/ml) and drugs for 60 min. Twenty mM NaCI was used in the case of 123 mM KCI. The in cubation was stopped by adding 0.1 ml of 150 mM LaCl3; and 5-10 min later, the vessels were incubated in buffer A containing 15 mM LaCl3 without CaCl2, and gassed with 100% 02 for 60 min to remove extracellularly bound 45Ca. At the end of the experiments, the vessels were blotted dry, weighed, and the 45Ca was then extracted by dissolving the vessels in 0.5 ml of Protosol® (Amersham) at 60°C for 1-3 hr. Then, 4 ml of scintillator (ACS 118, Amersham) was added, and the counts of 45Ca were measured with a liquid scintillation counter (Aloka, LSC-900, Nihon Musen). To remove 45Ca in the extracellular space, 3H-mannitol (7.55 ,uCi/ml) was added to the incubation buffer A containing 45Ca.
3. 45Ca-efflux experiments:
The vessels (rabbit aorta and dog portal vein: about 100 mg) were incubated in 5 ml of Ca-free buffer A at 37'C for about 2 hr, and then they were incubated in buffer A containing 45Ca (5 ,aCi/ 5 ml) for 2 hr. After the vessels were washed with Ca-free buffer A, 3 times, on ice, they were transferred to tubes containing 2 ml of Ca-free buffer A and incubated for 90 min at 37'C. Every 10 min, the vessels were trans ferred to another efflux medium (2 ml). The drugs were added to each efflux medium. Four ml of scintillator was added to 0.5 ml of each efflux medium, and the counts of 45Ca were measured. After the efflux experiments, the vessels were blotted, weighed, and dissolved in 0.5 ml Protosol at 60°C. Four ml of scintillator was added, and the residual 45Ca in the vessels was measured . The efflux rate coefficient (ERC) was calculated ac cording to the following formula (11) : ERC (%/min)=(C/Cmxt)x100, where C is the radioactivity lost from the tissue for 90 min, Cm is the mean radioactivity left in the tissue during the interval of the efflux measure ment, and t is 90 min; Cm was calculated as the average of the radioactivity per 10 mg tissue using the values at the beginning and the end of the 90 min-efflux measurement.
4. Pithed rats: Sprague-Dawley rats (male, 280-380 g, 8-9 week old) were anesthetized with ether. After tracheal intubation, the common carotid artery and jugular vein were catheterized with a polyethylene tube con taining heparinized saline (100 U/ml). Ani mals were pithed through one orbit with a steel rod and immediately ventilated with room-air using a rodent respirator (Natume, Model KN-56; tidal volume of 1 ml/100 g b.w., 45-60 cycles/min). The drugs and agonist (NE) were injected into the jugular vein at a volume of 0.5-1.0 ml/kg during 3-5 sec. Blood pressure was recorded con tinuously on the polygraph (San-ei, 142-8) via a pressure transducer (Nihon Kohden, MPU-0.5) from the carotid arterial catheter. The a, -adrenergic pressor response to N E was measured during the pretreatment with propranolol (1 mg/kg, i.v.) and yohimbine (1 mg/kg, i.v.) injected 15 min before NE was injected. The a2-adrenergic pressor response to NE was assessed during the pretreatment with propranolol (1 mg/kg, 1.v.) and prazosin (1 mg/kg, i.v.) administered 15 min before NE was injected. The drugs were injected 7 min after the treatment with propranolol and yohimbine (or prazosin).
5. Ganglion-blocked conscious SHR: Can nulae (PE-10 and PE-50) were inserted into the femoral artery and vein of male SHR (15 20 week old) anesthetized with pentobarbital (50 mg/kg, i.p.). The tips of both cannulae protruding from the back skin were tied at the neck. On the next day, the conscious animals were used. NE and phenylephrine at intervals of 5 min were injected into the femoral vein at 15 min and 5 min after pro pranolol (1 mg/kg, i.v.) and hexamethonium (20 mg/kg, i.p.), respectively. The a2 adrenergic pressor response was assessed 1 hr after prazosin (10 mg/kg, p.o.) was administered. CV-4093-2HCI was adminis tered orally after the first a, and a2 adrenergic pressor responses were assessed. Hexamethonium and propranolol were again administered before the assessment of the second responses. One animal was used for one dose of drug.
6. Drugs: The following agents were used: nifedipine, nicardipine and CV-4093.2HC1 were synthesized in our Chemistry Labora tories. Nifedipine and nicardipine (10-2 M) were dissolved in DMSO before use, and CV-4093-2HCI (10-2 M) was dissolved in 50% PEG 400 and 50% DMSO before use; Each 10-2 M solution was diluted with Krebs Henseleit buffer to the appropriate concen tration, and immediately, 20 ,ul of each diluted solution was added into the organ bath (final concentration of solvents: below 0.1%). In the case of the experiments on isolated, perfused kidney and mesentery, final con centrations of solvents were below 0.03% (kidney) and below 0.001% (mesentery). Nifedipine and nicardipine were prepared in brown glass tubes, and the organ baths containing these drugs were covered with alminium foil. 45CaC12 and 3H-mannitol were purchased from New England Nuclear (U.S.A).
7. Statistics: Data in the figures and Table  3 show the mean±S.E.M. Student's t-test was used for the 45Ca-efflux experiments , and Student's t-test or the Wilcoxon rank sum test was used for the experiments on the isolated, perfused kidney and mesenteric vascular beds and the ganglion-blocked SHR. IC50 (ID50) values were calculated from the concentration (dose)-% inhibition relations by the method of least squares. Ninety five % confidence limits of the IC50 (ID50) values were calculated according to Fieller's theorem (12) . Results 
In vitro experiments
1-1. Inhibitory action against the K+ induced contraction of rabbit aorta: In rabbit aorta, the inhibitory action of CV-4093.2HCI on the K+-induced contraction was slow in onset and long-lasting after the drug was withdrawn by washout, whereas the in hibitory effects of nifedipine and nicardipine occurred rapidly and disappeared rapidly after washout (Fig. 1) . Furthermore, the inhibitory effect of CV-4093.2HCI was slightly (but not significantly) enhanced by washout.
Therefore, in all the experiments , the preincubation time was 60 min for CV 4093.2HC1 and 30 min for nifedipine and nicardipine. The concentrations of nifedipine and nicardipine were increased after the responses of preparations were recovered, but in the case of CV-4093-2HCI, one prep aration was used for one concentration.
The IC50 values for the K+-induced contraction were 1.6x 10-6, 1.7x10-8 and 2.1x10-9 M for CV-4093.2HCI, nifedipine and nicardi pine, respectively (Table 1) .
1-2. Inhibitory action against the K+ induced contraction of dog blood vessels: The IC50 values of the agents to inhibit the contraction of blood vessels induced by KCI Table 2 .
Inhibitory effects of CV-4093.2HCI and nicardipine on K+-induced responses 1-3. Effect of CV-4093.2HCI on 45Ca flux: In rabbit aorta, 45Ca-influx was induced concentration-dependently by KCI : 22±3 (n=14), 51±11 (n=14) and 57±11 (n=7) nmole/g/hr for 2.7, 60 and 123 mM KCI, respectively. CV-4093.2HCI (10-5 M) did not inhibit 45Ca influx induced by 2.7 mM KCI; it has been reported that nicardipine also does not inhibit this 45Ca-influx (12) . As shown in Fig. 2a, IC50 values for the 45Ca influx induced by 60 mM KCI were 0.8 X 10-6 and 1.8X10-9 M for CV-4093.2HCI and nicardipine in the rabbit aorta. In dog portal vein, 40 mM KCI (submaximal concentration for contraction) was used, and 45Ca-influx by 40 mM KCI was 196±40 nmole/g/hr (n=20). CV-4093.2HCI and nicardipine in hibited 40 mM KCI-induced 45Ca-influx with IC50 values of 0.6 x 10-9 and 0.7 x 10-9 M, respectively (Fig. 2b) . Therefore, it is obvious that the IC50 values for the K+-induced con traction were almost identical to those for the K+-induced 45Ca-influx in the case of both CV-4093.2HCI
and nicardipine (Table  2 ).
In the 45Ca-efflux experiment, CV-4093 2HCI (10-5 M) did not affect the tissue residue of 45Ca and ERC in the rabbit aorta and the dog portal vein (Table 3) . • CV-4093.2HCI, AL nifedipine.
1-4. Inhibitory effect on the K+-induced vasoconstriction in the isolated, perfused kidneys and mesenteric vascular beds of SHR: As shown in Fig. 3a , CV-4093-2HC1 (10-9 M) inhibited the KCI (20 mg/kidney) induced increase in perfusion pressure (PP) by about 60%, and this inhibitory effect tended to be more effective than those of nifedipine and nicardipine, but not signifi cantly. At 10-8 M, CV-4093-2HCI inhibited KCI (10 mg)-induced increase in PP more effectively than did nifedipine (P<0.05) (Fig.  3b) . The inhibitory effect of CV-4093.2HC1 persisted for 2 hr after the withdrawal of the drug, but the effects of the other 2 drugs disappeared at 1 hr after washout (data not shown).
In the isolated, perfused mesenteric vas cular beds of SHR, the inhibitory effects of CV-4093.2HCI at 10-8 and 10-7 M were greater than that of nifedipine (P<0.05) (Fig.  4) and lasted for more than 2 hr after washout (data not shown). 2. In vivo experiments 2-1. Inhibitory effect on post a, and a2 adrenergic pressor responses in pithed rats: The average diastolic pressure of pithed rats was 49.7±1.3 mmHg (n=12). The cr, adrenergic pressor response to NE (1-30 /lg/ kg, i.v.) was dose-dependent in the pithed rats pretreated with both propranolol (1 mg/ kg, i.v.) and yohimbine (1 mg/kg, i.v.). Fifteen minutes after CV-4093-211CI and nicardipine (100 ug/kg, i.v.) were injected, the a, -adrenergic pressor response curve was shifted toward the right by 3-fold by both drugs (Fig. 5a) .
The a2-adrenergic pressor response of N E
(1-100 fig/kg, i.v.) was also dose-dependent in the rats given both propranolol (1 mg/kg, i.v.) and prazosin (1 mg/kg, i.v.), but was less than the a, -adrenergic pressor response. Fifteen minutes after CV-4093.2HCI and nicardipine (100 /,,g/kg, i.v.) were injected, the a2-adrenergic pressor response curve was shifted toward the right by 30-100-fold and 10-30-fold, respectively ( Fig. 5b) : CV 4093.2HCI was about 3 times more effective than nicardipine. On the other hand, pressor responses to the NE-a2 component were inhibited by CV-4093.2HCI
(3 mg/kg, p.o., n=4)
by 100, 96±4, 75±4 and 67±7%, respectively (Fig. 6 ). These findings indicate that the inhibitory effect of CV-4093.2HCI on the a2-induced pressor response was more pronounced than that on the a,-induced one (% inhibition of the pressor response to 1 ,ug/ kg of phenylephrine, i.v., vs. that to 1 ag/kg of NE, i.v. (a2): P<0.05, Wilcoxon rank sum test). Therefore, the inhibitory effects on the a2-induced pressor response to 10 ug/kg of NE, i.v., were compared between CV 4093.2HCI and nicardipine. The ID50 values for CV-4093. 2HC1 and nicardipine against the a2-adrenergic pressor responses (10 ug/ kg of NE, i.v.) were 1.8 and 6.8 mg/kg, p.o., respectively (Fig. 7) , indicating that CV 4093.2HCI was more effective (about 3 times) than nicardipine. These ID50 values were similar to the doses that showed an antihypertensive effect in SHR (6). 
Discussion
The contraction of smooth muscle induced by a high concentration of K+ is known to be due to the voltage-dependent Ca"-influx into the smooth muscle cells (13, 14) . The order of IC50 values for CV-4093.2HCI against K+-induced contraction and K+ induced 45 Ca"-Influx were almost identical ( Table 2) and CV-4093.2HCI did not affect the Ca" efflux (Table 3 ) and the Las+ resistant Ca"-Influx. These findings indicate that the inhibitory effect of CV-4093.2HCI as well as those of nicardipine and nifedipine on K+-induced contraction of the blood vessel is due to the inhibition of the voltage-dependent Ca++-channel.
The inhibitory effect of CV-4093.2HCI against the K+-induced contraction was slow in onset and lasted for a long time after washout of the drug (Fig. 1) . Okabe et al. (7) have observed both phenomena (slow onset of the action and unwashable effect) in the inhibitory effect of CV-4093.2HC1 on the Ca inward current in single smooth muscle cells of the rabbit main pulmonary artery, which was examined by the single electrode voltage clamp method. Although the mechanisms related to these phenomena remain to be clarified, the hardly washable nature of CV 4093.2HC1 might partly contribute to the long antihypertensive action of this drug in SHR (6) .
The inhibitory effect of CV-4093.2HC1 on the K+-induced contraction of the rabbit aorta was slightly enhanced by washout of the drug (Fig. 1 b) , but the mechanism of this phenomenon remains unclear.
CV-4093.2HCI inhibited less effectively the K+-induced contraction of the isolated strips of dog renal and mesenteric artery than nifedipine and nicardipine did, whereas the inhibitory potency of CV-4093.2HCI on the K+-induced contraction of the isolated dog portal vein and femoral vein was equivalent to those of nifedipine and nicardipine (Table  1) . In the isolated, perfused kidney and mesenteric vascular beds of SHR, CV-4093• 2HCI inhibited the increase in perfusion pressure induced by KCI more effectively (slightly but significantly) than nifedipine (Figs. 3 and 4) . Moreover, the antihyper tensive effect of CV-4093.2HCI in SHR was more pronounced than that of nifedipine and nicardipine (6) .
These findings suggest that CV-4093• 2HCI, unlike nifedipine and nicardipine, induces Ca" channel blocking action de pending on the blood vessels, and CV-4093• 2HCI seems to cause a more pronounced vasodilator effect in the perfused organ or in the whole animal experiments than on the contraction of isolated vascular muscle strips, as compared with nifedipine and nicardipine. It is difficult to make any firm conclusions about the detailed subcellular mechanism involved in this differential action of CV 4093.2HCI from the observations in the present study. Nevertheless, we consider that at least two mechanisms may con tribute to these findings. First, the inhibitory effects of CV-4093.2HCI on the KCI-induced increase in perfusion pressure in the isolated, perfused kidney and mesenteric vascular beds might be due to the dilating effects on the resistance vessel-like arterioles, and this may be partly responsible for the more effective antihypertensive effect of CV-4093-21-10 in vivo in SHR as compared to those of nifedi pine and nicardipine (6) . The findings of Cauvin and co-workers (15) that the distal portion of rabbit mesenteric artery exhibited a similar pharmacological response to that of the resistance artery may support this view. On the other hand, the isolated dog vascular smooth muscle strips used in our experiments do not represent the resistance vessels. For example, the diameters of dog mesenteric and renal arteries were larger than 0.2 mm, while Furuta reported that the very small mesenteric artery of the rabbit (about 0.2 mm in outer diameter) may represent a resistance vessel (16) . Thus, CV-4093.2HCI might have a more efficient effect on the resistance vasculature than the other 2 dihydropyridines.
Secondly, CV-4093.2_HCI inhibited the post a2-adre noceptor-mediated pressor responses in the pithed rats (Fig. 5 ) and ganglion-blocked SHR (Fig. 7) more effectively (slightly but significantly)
than did nicardipine at the doses that elicit the antihypertensive effect. This more effective inhibition on the post a2 adrenoceptor pressor response may be partly responsible for the more effective antihyper tensive effect of CV-4093.2HCI as compared to those of nifedipine and nicardipine in SHR (6) . Although it has been shown that the postsynaptic a2-adrenoceptor-mediated re sponse is more dependent on Ca"-Influx via receptor-operated Ca" channels com pared with the a,-mediated response (17 20) , mechanisms underlying the differential effects of these two compounds are not clear and await further study.
